vimarsana.com

Page 72 - ரஷ்யா அமைச்சகம் ஆஃப் வெளிநாட்டு வாழ்க்கைத்தொழில்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine update: Russia to test samples of Sputnik V produced in India; 300 million dose target for 2021

: Friday, December 18, 2020, 1:35 PM IST COVID-19 vaccine update: Russia to test samples of Sputnik V produced in India; 300 million dose target for 2021 File Photo Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev has said that Russia is testing the first samples of Sputnik V COVID-19 vaccine produced in India. The Russian Embassy in India further said that 300 million doses of the COVID-19 vaccine will be produced in India, in 2021. Russian Direct Investment Fund (RDF) CEO Kirill Dmitriev says Russia is testing the first samples of its SputnikV #COVID19 vaccine that were produced in India. 300 mn doses will be produced by India in 2021: Russian Embassy in India ANI (@ANI) December 18, 2020

India to produce 300 million doses of Sputnik V COVID vaccine: Russian Direct Investment Fund

India to produce 300 million doses of Sputnik V COVID vaccine: Russian Direct Investment Fund The Russian embassy in India on Friday, quoting the RDIF CEO, said that Russia is testing the first samples of its Sputnik V vaccine against COVID-19 that were produced in India. Share Via Email   |  A+A A- A nurse prepares to inoculate a volunteer with Russia s Sputnik-V COVID vaccine at a clinic in Moscow. (File photo| AFP) By ANI MOSCOW: India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said. In India, we have agreements with four large manufacturers.. India will produce about 300 million doses or more of the vaccine for us next year, he said, in an interview to Rossiya 24 TV channel, quoted by Tass News Agency.

Sputnik V: India to produce about 300 mn doses of Russian vaccine in 2021

Sputnik V: India to produce about 300 mn doses of Russian vaccine in 2021 A health worker dressed in PPE takes an oral swab sample from a passenger in a Covid-19 screening area. (Bloomberg)Premium Share Via Read Full Story CEO of Russian Direct Investment Fund (RDIF) Kirill Dmitriev has said that India is planning to produce around 300 million doses of the Russian Sputnik V Covid-19 vaccine next year. In India, we have agreements with four large manufacturers. . India will produce about 300 mln doses or more of the vaccine for us next year, Kirill Dmitriev told Tass News Agency in an interview, adding that production was expected to start in early 2021.

우윤근 특사 러, 푸틴 대통령 내년 상반기 방한 긍정검토 밝혀

우윤근 특사 러, 푸틴 대통령 내년 상반기 방한 긍정검토 밝혀
mk.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mk.co.kr Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.